Nicole Saphier discloses diverse stock holdings ahead of Surgeon General hearing

Nicole Saphier, President Donald Trump’s nominee for Surgeon General, has released financial disclosures ahead of her September 16 confirmation hearing. The filings reveal a diverse portfolio of investments that include holdings in the tobacco, pharmaceutical, technology, and fast food industries.

Specific holdings include tobacco companies such as Philip Morris International, Altria, and British American Tobacco, as well as major pharmaceutical firms like Eli Lilly, Johnson & Johnson, Pfizer, and Merck. Her portfolio also contains significant tech stocks, including Nvidia, Apple, and Amazon, along with energy companies like Exxon Mobil and Chevron. Additionally, she holds interests in beverage and fast food companies such as Coca-Cola, PepsiCo, and McDonald’s.

Saphier has pledged to divest from these companies if confirmed. The disclosures also note potential royalties from her authored books and her previous role as a Fox News contributor. She has discontinued her podcast, Wellness Unmasked, in preparation for the confirmation process.